U.S.-based hedge fund Viking Global built a $526 million-worth new position in planemaker Boeing in the fourth quarter, with 2.9 million shares, a regulatory filing showed on Friday.
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...
As previously reported, Scotiabank analyst George Farmer initiated coverage of Viking Therapeutics (VKTX) with an Outperform rating and $102 ...
Viking Therapeutics stock jumped higher last year because it looks like a dual GLP-1/GIP agonist it's developing could ...
Viking Therapeutics stock plunged early Thursday on an earnings report that included mostly incremental updates for its ...
Viking Therapeutics announces its fourth-quarter financial results after Wednesday's closing bell. Here's a look at the ...
Shares of Viking Therapeutics (VKTX) slid 8% post-market after the biotech company issued its Q4 earnings report and a pipeline update. Read more here.
Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...
On Jan. 27, Nvidia (NASDAQ: NVDA) fell 17%, erasing over $590 billion from its market cap. It marked the greatest single-day ...
President Donald Trump wrote that Canada “doesn’t even allow U.S. banks to open or do business there.” It isn’t true.
Dow Jones e-commerce giant Amazon stock is in buy range above its latest entry ahead of this week's Q4 earnings report.